Palleon Pharmaceuticals
2015
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A
LATEST DEAL TYPE
$47.6M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer. The company's biotechnology platform integrates technologies and insights from scientific leaders all over the world in the fields of glycoscience and human immunology to create a novel approach to treating cancer by targeting multiple immune cell types, providing physicians with a wider range of rational combination therapies to treat cancer and tackle resistance to first-generation immuno-oncology agents.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 266 Second Avenue
- Waltham, MA 02451
- United States
+1 (857) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Palleon Pharmaceuticals’s full profile, request a free trial.
Palleon Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 04-Oct-2017 | $47.6M | 000.00 | 000.00 | Completed | Pre-Clinical Trials |
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Palleon Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 000 |
Palleon Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| AbbVie Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Pfizer Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SR One | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Takeda Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Vertex Ventures HC | Venture Capital | Minority | 000 0000 | 000000 0 |
Palleon Pharmaceuticals Executive Team (4)
Palleon Pharmaceuticals Board Members (10)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| James Broderick MD | Palleon Pharmaceuticals | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Jayson Punwani Ph.D | Self | Board Member | 000 0000 | |
| Jens Eckstein Ph.D | SR One | Board Member | 000 0000 | |
| Lori Hu | Vertex Ventures HC | Board Member | 000 0000 | |
| Margarita Chavez JD | AbbVie Ventures | Board Observer | 000 0000 |
3 Former Board Members
You’re viewing 5 of 10 board members. Get the full list »